Telbivudine

Janessa M. Smith, Pharm.D., BCPS, Paul A. Pham, Pharm.D.
Pediatric Dosing Author: Alice Jenh Hsu, PharmD, BCPS, AQ-ID
Telbivudine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:

Pediatrics Central

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Treatment of chronic hepatitis B (HBeAg-negative or -positive) with ongoing viral replication and evidence of transferase elevation or histologically active disease.

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 8, 2018

Citation

* When formatting your citation, note that all book, journal, and database titles should be italicized* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Telbivudine ID - 540539 A1 - Pham,Paul,Pharm.D. AU - Smith,Janessa,Pharm.D., BCPS Y1 - 2018/07/08/ BT - Johns Hopkins ABX Guide UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540539/all/Telbivudine PB - The Johns Hopkins University DB - Pediatrics Central DP - Unbound Medicine ER -